بدائل البحث:
aromatic decrease » dramatic decrease (توسيع البحث)
somatic decrease » dramatic decrease (توسيع البحث)
small decrease » small increased (توسيع البحث)
يعرض 701 - 720 نتائج من 2,241 نتيجة بحث عن '(( aromatic decrease ) OR ( ((somatic decrease) OR (small decrease)) ))', وقت الاستعلام: 0.50s تنقيح النتائج
  1. 701

    Table 1_Bevacizumab and anlotinib combination therapy acts via HIF-1α suppression to exert synergistic anti-angiogenic and anti-tumor effects in non-small cell lung cancer.docx حسب Nafeisha Simayi (22262161)

    منشور في 2025
    "…Introduction<p>Tumor angiogenesis is required for the progression of non-small cell lung cancer (NSCLC), and anti-vascular endothelial growth factor (anti-VEGF) antibody bevacizumab and multitarget tyrosine kinase inhibitor anlotinib are anti-cancer treatment options, the combined effect of which in NSCLC remains unclear.…"
  2. 702

    Data Sheet 2_Bevacizumab and anlotinib combination therapy acts via HIF-1α suppression to exert synergistic anti-angiogenic and anti-tumor effects in non-small cell lung cancer.pdf... حسب Nafeisha Simayi (22262161)

    منشور في 2025
    "…Introduction<p>Tumor angiogenesis is required for the progression of non-small cell lung cancer (NSCLC), and anti-vascular endothelial growth factor (anti-VEGF) antibody bevacizumab and multitarget tyrosine kinase inhibitor anlotinib are anti-cancer treatment options, the combined effect of which in NSCLC remains unclear.…"
  3. 703

    Data Sheet 1_Bevacizumab and anlotinib combination therapy acts via HIF-1α suppression to exert synergistic anti-angiogenic and anti-tumor effects in non-small cell lung cancer.zip... حسب Nafeisha Simayi (22262161)

    منشور في 2025
    "…Introduction<p>Tumor angiogenesis is required for the progression of non-small cell lung cancer (NSCLC), and anti-vascular endothelial growth factor (anti-VEGF) antibody bevacizumab and multitarget tyrosine kinase inhibitor anlotinib are anti-cancer treatment options, the combined effect of which in NSCLC remains unclear.…"
  4. 704
  5. 705

    Dose-dependent neuroprotection by HIFN. حسب Shweta Modgil (12864344)

    منشور في 2025
    الموضوعات:
  6. 706
  7. 707
  8. 708
  9. 709
  10. 710
  11. 711
  12. 712
  13. 713
  14. 714
  15. 715
  16. 716

    Image 2_Spatial deciphering of the transcriptomic heterogeneity of tumor spread through air spaces in lung cancer.tif حسب Wenhao Wang (515852)

    منشور في 2025
    "…Meanwhile, an increase in CD4 T memory cells and a decrease in B cells were observed in the tumor immune microenvironment of STAS. …"
  17. 717

    Image 4_Spatial deciphering of the transcriptomic heterogeneity of tumor spread through air spaces in lung cancer.tif حسب Wenhao Wang (515852)

    منشور في 2025
    "…Meanwhile, an increase in CD4 T memory cells and a decrease in B cells were observed in the tumor immune microenvironment of STAS. …"
  18. 718

    Data Sheet 1_Spatial deciphering of the transcriptomic heterogeneity of tumor spread through air spaces in lung cancer.zip حسب Wenhao Wang (515852)

    منشور في 2025
    "…Meanwhile, an increase in CD4 T memory cells and a decrease in B cells were observed in the tumor immune microenvironment of STAS. …"
  19. 719

    Image 1_Spatial deciphering of the transcriptomic heterogeneity of tumor spread through air spaces in lung cancer.tif حسب Wenhao Wang (515852)

    منشور في 2025
    "…Meanwhile, an increase in CD4 T memory cells and a decrease in B cells were observed in the tumor immune microenvironment of STAS. …"
  20. 720

    Image 3_Spatial deciphering of the transcriptomic heterogeneity of tumor spread through air spaces in lung cancer.tif حسب Wenhao Wang (515852)

    منشور في 2025
    "…Meanwhile, an increase in CD4 T memory cells and a decrease in B cells were observed in the tumor immune microenvironment of STAS. …"